President Donald Trump signed an executive order Thursday setting the stage for tariffs as high as 100% on certain patented prescription drugs and their ingredients, while offering lower rates or exemptions to companies that strike “most favored nation” pricing agreements and build manufacturing capacity in the United States. Under the policy, a 0% tariff would apply to drugmakers that both enter most-favored-nation pricing deals with the Department of Health and Human Services and are actively

Tag-uri: Donald Trump